Approval · Notice of Compliance 28457 · 2022
VARIZIG: Notice of Compliance 28457
Issued June 23, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28457
- Date
- June 23, 2022
- Company
- Ki Biopharma LlcWilmington, Delaware, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VARIZIG | 02442183 | Marketed |
Medicinal ingredients
- VARICELLA-ZOSTER IMMUNE GLOBULIN HUMAN 125 UNIT per VIAL